Review: taking Ritalin and Risperdal consta together


Summary

Drug interactions are reported among people who take Ritalin and Risperdal consta together. This review analyzes the effectiveness and drug interactions between Ritalin and Risperdal consta. It is created by eHealthMe based on reports of 1,688 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Ritalin

Ritalin has active ingredients of methylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. (latest outcomes from Ritalin 14,979 users)

Risperdal Consta

Risperdal consta has active ingredients of risperidone. It is often used in schizophrenia. (latest outcomes from Risperdal consta 9,261 users)

On Sep, 27, 2016

1,688 people who take Ritalin, Risperdal Consta are studied.


Number of reports submitted per year:

Ritalin and Risperdal consta drug interactions.

Drug effectiveness over time:

Ritalin:
  • < 1 month: 20.0% - (2 of 10 people)
  • 1 - 6 months: 10.0% - (1 of 10 people)
  • 6 - 12 months: 100.0% - (2 of 2 people)
  • 1 - 2 years: 52.0% - (10 of 19 people)
  • 2 - 5 years: 29.0% - (5 of 17 people)
  • 5 - 10 years: 50.0% - (1 of 2 people)
  • 10+ years: 50.0% - (1 of 2 people)
  • not specified: 0.0% - (0 of 1 people)
Risperdal Consta:
  • < 1 month: 18.0% - (2 of 11 people)
  • 1 - 6 months: 16.0% - (2 of 12 people)
  • 6 - 12 months: 28.0% - (2 of 7 people)
  • 1 - 2 years: 23.0% - (3 of 13 people)
  • 2 - 5 years: 38.0% - (5 of 13 people)
  • 5 - 10 years: 60.0% - (3 of 5 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 50.0% - (1 of 2 people)

Drug effectiveness by gender:

Ritalin:
  • female: 21.0% - (5 of 23 people)
  • male: 42.0% - (17 of 40 people)
Risperdal Consta:
  • female: 33.0% - (7 of 21 people)
  • male: 25.0% - (11 of 43 people)

Drug effectiveness by age:

Ritalin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 29.0% - (5 of 17 people)
  • 10-19: 39.0% - (9 of 23 people)
  • 20-29: 25.0% - (3 of 12 people)
  • 30-39: 33.0% - (2 of 6 people)
  • 40-49: 100.0% - (2 of 2 people)
  • 50-59: 0.0% - (0 of 2 people)
  • 60+: 100.0% - (1 of 1 people)
Risperdal Consta:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 10.0% - (2 of 19 people)
  • 10-19: 28.0% - (6 of 21 people)
  • 20-29: 30.0% - (4 of 13 people)
  • 30-39: 66.0% - (4 of 6 people)
  • 40-49: 33.0% - (1 of 3 people)
  • 50-59: 50.0% - (1 of 2 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • aggression
  • agitation
  • dyskinesia
  • rhabdomyolysis
  • gynaecomastia
  • tachycardia
  • convulsion
  • tremor
  • dehydration
  • emotional distress
1 - 6 months:
  • gynaecomastia
  • weight increased
  • abnormal behaviour
  • insomnia
  • drug ineffective
  • type 1 diabetes mellitus
  • diabetes mellitus
  • hallucination, visual
  • application site erythema
  • chest discomfort
6 - 12 months:
  • tic
  • hyperhidrosis
  • tachycardia
  • abnormal behaviour
  • fatigue
  • aggression
  • cough
  • night sweats
  • blood triglycerides increased
  • gynaecomastia
1 - 2 years:
  • gynaecomastia
  • emotional distress
  • weight increased
  • obesity
  • emotional disorder
  • diabetes mellitus
  • decreased appetite
  • tic
  • type 2 diabetes mellitus
  • weight decreased
2 - 5 years:
  • gynaecomastia
  • weight increased
  • emotional distress
  • emotional disorder
  • aggression
  • obesity
  • dyskinesia
  • agitation
  • dehydration
  • hyperthermia
5 - 10 years:
  • gynaecomastia
  • weight increased
  • emotional distress
  • emotional disorder
  • obesity
  • abnormal weight gain
  • hyperprolactinaemia
  • type 2 diabetes mellitus
  • abnormal behaviour
  • blood triglycerides increased
10+ years:
  • gynaecomastia
  • emotional distress
  • weight increased
  • thyroid disorder
  • tic
  • type 2 diabetes mellitus
  • dyskinesia
  • emotional disorder
  • obesity
  • abnormal behaviour
not specified:
  • weight increased
  • drug ineffective
  • aggression
  • abnormal behaviour
  • gynaecomastia
  • agitation
  • insomnia
  • depression
  • suicidal ideation
  • dizziness

Most common drug interactions by gender *:

female:
  • drug ineffective
  • dizziness
  • agitation
  • depression
  • insomnia
  • pain
  • weight increased
  • diabetes mellitus
  • suicidal ideation
  • anxiety
male:
  • gynaecomastia
  • weight increased
  • aggression
  • emotional distress
  • abnormal behaviour
  • drug ineffective
  • agitation
  • dyskinesia
  • tic
  • insomnia

Most common drug interactions by age *:

0-1:
  • aggression
  • convulsion
  • agitation
  • foaming at mouth
  • pancreatitis acute
  • tardive dyskinesia
2-9:
  • aggression
  • dyskinesia
  • abnormal behaviour
  • tachycardia
  • agitation
  • drug ineffective
  • hyperthermia
  • dystonia
  • tic
  • drug administration error
10-19:
  • weight increased
  • drug ineffective
  • abnormal behaviour
  • aggression
  • insomnia
  • suicide attempt
  • diabetes mellitus
  • agitation
  • decreased appetite
  • weight decreased
20-29:
  • insomnia
  • dizziness
  • dyspnoea
  • paranoia
  • asthenia
  • completed suicide
  • deep vein thrombosis
  • hallucination, auditory
  • headache
  • hypokalaemia
30-39:
  • diabetes mellitus
  • depression
  • insomnia
  • mania
  • suicidal ideation
  • priapism
  • ventricular tachycardia
  • psychotic disorder
  • palpitations
  • aggression
40-49:
  • type 2 diabetes mellitus
  • depression
  • blood cholesterol increased
  • insomnia
  • obesity
  • road traffic accident
  • somnolence
  • speech disorder
  • chest pain
  • diarrhoea
50-59:
  • dizziness
  • paraesthesia
  • nausea
  • type 2 diabetes mellitus
  • depression
  • suicide attempt
  • weight increased
  • extrapyramidal disorder
  • muscle twitching
  • parkinsonism
60+:
  • dyspnoea
  • pain
  • pneumonia
  • drug ineffective
  • malaise
  • urinary tract infection
  • anxiety
  • depression
  • insomnia
  • pain in extremity

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Ritalin and Risperdal consta?

Can you answer these questions?

More questions for: Ritalin, Risperdal consta

You may be interested in these reviews

More reviews for: Ritalin, Risperdal consta

On eHealthMe, Ritalin (methylphenidate hydrochloride) is often used to treat attention deficit hyperactivity disorder. Risperdal consta (risperidone) is often used to treat schizophrenia. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.